Replacement of unfractionated heparin by low-molecular-weight heparin for postorthopedic surgery antithrombotic prophylaxis lowers the overall risk of symptomatic thrombosis because of a lower frequency of heparin-induced thrombocytopenia
- 15 October 2005
- journal article
- Published by American Society of Hematology in Blood
- Vol. 106 (8) , 2921-2922
- https://doi.org/10.1182/blood-2005-05-1824
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Heparin is not required for detection of antibodies associated with heparin-induced thrombocytopenia/thrombosisJournal of Laboratory and Clinical Medicine, 2001
- Gefahrenpotentiale in der medikamentösen Thromboseprophylaxe - niedermolekuläre Heparine versus StandardheparinZeitschrift für Orthopädie und ihre Grenzgebiete, 1999
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated HeparinNew England Journal of Medicine, 1995
- Heparin-associated thrombosis despite normal platelet countsThe Lancet, 1994